Prices are closing data as of 2026-11-04, not real-time quotes. HK P/E and P/B multiples come from Eastmoney HK key statistics. Metric definitions: P/E, P/B, ROE.
Want the full AI research report for HUTCHMED?
This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.
New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.
10-Year FinancialsFY2016–2025
Financial statements are reported in USD, while share price and market cap are quoted in HKD.
Key Multi-Year Facts
- Revenue moved from $206.1M in FY2016 to $468.0M in FY2025 (9-year CAGR +9.5%).
- Net income was negative in FY2017, FY2018, FY2019, FY2020, FY2021, FY2022.
- Operating cash flow was below half of net income in FY2016, FY2024, FY2025.
Latest 5 Fiscal Years
| Fiscal Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue (USD B) | 0.32 | 0.39 | 0.53 | 0.52 | 0.47 |
| YoY | 42.3% | 21.3% | 36.7% | -2.0% | -9.3% |
| Net Income (USD B) | -0.19 | -0.36 | 0.10 | 0.04 | 0.46 |
| YoY | — | — | — | -62.6% | 1111.0% |
| Operating Cash Flow (USD B) | -1.30 | -1.87 | 1.55 | 0.00 | -0.45 |
| ROE | -26.5% | -45.2% | 15.0% | 5.1% | 45.7% |
| Gross Margin | 26.7% | 29.3% | 36.1% | 42.5% | 37.6% |
| Net Margin | -61.3% | -93.7% | 19.1% | 7.3% | 97.6% |
| Debt-to-Assets | 24.3% | 38.1% | 41.9% | 39.4% | 28.6% |
Show all 10 fiscal years
| Fiscal Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD B) | 0.21 | 0.23 | 0.20 | 0.20 | 0.22 | 0.32 | 0.39 | 0.53 | 0.52 | 0.47 |
| YoY | — | 12.4% | -13.0% | 0.3% | 10.3% | 42.3% | 21.3% | 36.7% | -2.0% | -9.3% |
| Net Income (USD B) | 0.01 | -0.03 | -0.07 | -0.11 | -0.13 | -0.19 | -0.36 | 0.10 | 0.04 | 0.46 |
| YoY | — | -328.6% | — | — | — | — | — | — | -62.6% | 1111.0% |
| Operating Cash Flow (USD B) | -0.07 | -0.06 | -0.23 | -0.56 | -0.40 | -1.30 | -1.87 | 1.55 | 0.00 | -0.45 |
| ROE | 6.3% | -8.3% | -17.6% | -31.3% | -32.6% | -26.5% | -45.2% | 15.0% | 5.1% | 45.7% |
| Gross Margin | 24.2% | 24.8% | 32.9% | 21.8% | 18.2% | 26.7% | 29.3% | 36.1% | 42.5% | 37.6% |
| Net Margin | 5.7% | -11.5% | -37.1% | -52.4% | -56.4% | -61.3% | -93.7% | 19.1% | 7.3% | 97.6% |
| Debt-to-Assets | 40.4% | 18.9% | 22.5% | 32.7% | 28.3% | 24.3% | 38.1% | 41.9% | 39.4% | 28.6% |
Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: HKEX / Eastmoney financial statements, compiled mechanically without AI. Official filings
Risk ChecklistAs of 2026-11-05
Rules-based screening using HK financial statements and HKEX announcement categories (no AI opinions).
Items Flagged for Review
-
Alert
Cash ConversionFinancial Quality
OCF / Net Income: FY2025 (2025-12-31) -0.99, FY2024 (2024-12-31) 0.09
FY2025 (ended 2025-12-31) · What is this?
An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.
Dividends
No dividends paid over the trailing 12 months.
Figures are gross HKD per share before applicable withholding or Stock Connect dividend taxes.
More data: All research reports · Sector leaders · Market hours & holidays.
Compiled mechanically from public filings and market quotes (data as of 2026-11-05). For informational purposes only, not investment advice.